HPV vaccine acceptance among mid-adult women

Daron Gale Ferris, Jennifer L Waller, Ashley Owen, Jozette Smith

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalJournal of the American Board of Family Medicine
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Papillomavirus Vaccines
Odds Ratio
Vaccines
Logistic Models
Papanicolaou Test
Papillomavirus Infections
Uterine Cervical Neoplasms
Vaccination
Demography

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

HPV vaccine acceptance among mid-adult women. / Ferris, Daron Gale; Waller, Jennifer L; Owen, Ashley; Smith, Jozette.

In: Journal of the American Board of Family Medicine, Vol. 21, No. 1, 01.01.2008, p. 31-37.

Research output: Contribution to journalArticle

@article{d3a26cefd796435e93c2b7a9f47fff35,
title = "HPV vaccine acceptance among mid-adult women",
abstract = "Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95{\%} CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95{\%} CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95{\%} CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95{\%} CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95{\%} CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95{\%} CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95{\%} CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.",
author = "Ferris, {Daron Gale} and Waller, {Jennifer L} and Ashley Owen and Jozette Smith",
year = "2008",
month = "1",
day = "1",
doi = "10.3122/jabfm.2008.01.070103",
language = "English (US)",
volume = "21",
pages = "31--37",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "1",

}

TY - JOUR

T1 - HPV vaccine acceptance among mid-adult women

AU - Ferris, Daron Gale

AU - Waller, Jennifer L

AU - Owen, Ashley

AU - Smith, Jozette

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.

AB - Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.

UR - http://www.scopus.com/inward/record.url?scp=38549141173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549141173&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2008.01.070103

DO - 10.3122/jabfm.2008.01.070103

M3 - Article

C2 - 18178700

AN - SCOPUS:38549141173

VL - 21

SP - 31

EP - 37

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 1

ER -